Comorbid Conditions and Complications in Body Contouring Surgery: A Retrospective Review.
Abstract
[BACKGROUND] Body contouring procedures have significantly increased in popularity in the United States.
[OBJECTIVES] The authors sought to understand, categorize, and classify patients' experiences with postoperative complications following common body contouring procedures.
[METHODS] PearlDiver (PearlDiver Technologies, Colorado Springs, CO), a database with over 90 million patients, was queried to identify patients who had undergone body contouring procedures between 2010 and 2021 using current procedural terminology (CPT) codes. The authors identified patients who underwent panniculectomy, abdominoplasty, brachioplasty, thighplasty, mastopexy, breast augmentation, augmentation mastopexy, breast reduction, and liposuction for analysis. They reviewed combined procedures and analyzed risk factors associated with the most common complications.
[RESULTS] There were 243,886 patients included in the study. The majority of patients were female, between 50 and 59 years old, and had their procedures performed in the southern United States. There were an average of 25,352 procedures per year. The majority of cases involved breast surgeries. The most common preoperative comorbid conditions diagnosed 1 year before surgery were hypertension, obesity, and diabetes. The most common postoperative complications within 90 days were wound dehiscence, hematoma, and urinary tract infection. A logistic regression evaluating the association of the preoperative comorbid conditions with postoperative complications found that patients with obesity, tobacco use, diabetes, and hypertension had an increased risk of developing wound dehiscence, hematoma, and surgical-site infection.
[CONCLUSIONS] The data suggest that patients with obesity, tobacco use, diabetes, and hypertension undergoing body contouring surgery are at greater risk of developing wound dehiscence, hematomas, and surgical-site infections. Understanding this data is imperative for providers to adequately identify associated risk factors, stratify patients, and provide adequate perioperative counseling.
[OBJECTIVES] The authors sought to understand, categorize, and classify patients' experiences with postoperative complications following common body contouring procedures.
[METHODS] PearlDiver (PearlDiver Technologies, Colorado Springs, CO), a database with over 90 million patients, was queried to identify patients who had undergone body contouring procedures between 2010 and 2021 using current procedural terminology (CPT) codes. The authors identified patients who underwent panniculectomy, abdominoplasty, brachioplasty, thighplasty, mastopexy, breast augmentation, augmentation mastopexy, breast reduction, and liposuction for analysis. They reviewed combined procedures and analyzed risk factors associated with the most common complications.
[RESULTS] There were 243,886 patients included in the study. The majority of patients were female, between 50 and 59 years old, and had their procedures performed in the southern United States. There were an average of 25,352 procedures per year. The majority of cases involved breast surgeries. The most common preoperative comorbid conditions diagnosed 1 year before surgery were hypertension, obesity, and diabetes. The most common postoperative complications within 90 days were wound dehiscence, hematoma, and urinary tract infection. A logistic regression evaluating the association of the preoperative comorbid conditions with postoperative complications found that patients with obesity, tobacco use, diabetes, and hypertension had an increased risk of developing wound dehiscence, hematoma, and surgical-site infection.
[CONCLUSIONS] The data suggest that patients with obesity, tobacco use, diabetes, and hypertension undergoing body contouring surgery are at greater risk of developing wound dehiscence, hematomas, and surgical-site infections. Understanding this data is imperative for providers to adequately identify associated risk factors, stratify patients, and provide adequate perioperative counseling.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | breast
|
유방 | dict | 3 | |
| 합병증 | wound dehiscence
|
상처열개 | dict | 3 | |
| 시술 | mastopexy
|
유방성형술 | dict | 2 | |
| 합병증 | hematoma
|
혈종 | dict | 2 | |
| 합병증 | infection
|
감염 | dict | 2 | |
| 시술 | breast augmentation
|
유방성형술 | dict | 1 | |
| 시술 | breast reduction
|
유방성형술 | dict | 1 | |
| 시술 | liposuction
|
지방흡입 | dict | 1 | |
| 시술 | panniculectomy
|
복부성형술 | dict | 1 | |
| 시술 | abdominoplasty
|
복부성형술 | dict | 1 | |
| 시술 | brachioplasty
|
상완성형술 | dict | 1 | |
| 시술 | thighplasty
|
허벅지거상술 | dict | 1 | |
| 해부 | urinary tract
|
scispacy | 1 | ||
| 합병증 | wound
|
scispacy | 1 | ||
| 합병증 | hematomas
|
scispacy | 1 | ||
| 약물 | CPT
→ current procedural terminology
|
C1138431
Current Procedural Terminology
|
scispacy | 1 | |
| 약물 | [BACKGROUND] Body
|
scispacy | 1 | ||
| 약물 | [OBJECTIVES]
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS]
|
scispacy | 1 | ||
| 질환 | hypertension
|
C0020538
Hypertensive disease
|
scispacy | 1 | |
| 질환 | obesity
|
C0028754
Obesity
|
scispacy | 1 | |
| 질환 | diabetes
|
C0011847
Diabetes
|
scispacy | 1 | |
| 질환 | urinary tract infection
|
C0042029
Urinary tract infection
|
scispacy | 1 | |
| 질환 | surgical-site infection
|
C0038941
Surgical Wound Infection
|
scispacy | 1 | |
| 질환 | hematomas
|
C0018944
Hematoma
|
scispacy | 1 | |
| 질환 | surgical-site infections
|
C0038941
Surgical Wound Infection
|
scispacy | 1 | |
| 기타 | Body
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | tobacco
|
scispacy | 1 |
📑 인용 관계
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.